262 related articles for article (PubMed ID: 37313172)
1. Changes in the expression of cancer- and metastasis-related genes and proteins after metformin treatment under different metabolic conditions in endometrial cancer cells.
Lange C; Brüggemann J; Thüner T; Jauckus J; Strowitzki T; Germeyer A
Heliyon; 2023 Jun; 9(6):e16678. PubMed ID: 37313172
[TBL] [Abstract][Full Text] [Related]
2. Changes in protein expression due to metformin treatment and hyperinsulinemia in a human endometrial cancer cell line.
Lange C; Machado Weber A; Schmidt R; Schroeder C; Strowitzki T; Germeyer A
PLoS One; 2021; 16(3):e0248103. PubMed ID: 33690729
[TBL] [Abstract][Full Text] [Related]
3. [Molecular action of insulin-sensitizing agents].
Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive effects of metformin on obesity-associated endometrial proliferation.
Zhang Q; Celestino J; Schmandt R; McCampbell AS; Urbauer DL; Meyer LA; Burzawa JK; Huang M; Yates MS; Iglesias D; Broaddus RR; Lu KH
Am J Obstet Gynecol; 2013 Jul; 209(1):24.e1-24.e12. PubMed ID: 23500454
[TBL] [Abstract][Full Text] [Related]
5. Metformin augments the levels of molecules that regulate the expression of the insulin-dependent glucose transporter GLUT4 in the endometria of hyperinsulinemic PCOS patients.
Carvajal R; Rosas C; Kohan K; Gabler F; Vantman D; Romero C; Vega M
Hum Reprod; 2013 Aug; 28(8):2235-44. PubMed ID: 23595973
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of midkine by metformin can contribute to its anticancer effects in malignancies: A proposal mechanism of action of metformin in context of endometrial cancer prevention and therapy.
Karadeniz Z; Aynacıoğlu AŞ; Bilir A; Tuna MY
Med Hypotheses; 2020 Jan; 134():109420. PubMed ID: 31634770
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of metformin in the treatment of estrogen-dependent endometrial carcinoma complicated with type 2 diabetes mellitus and analysis of its prognosis.
Deng Y; Wang J; Li W; Xiong W; Wang X
J BUON; 2020; 25(3):1534-1540. PubMed ID: 32862601
[TBL] [Abstract][Full Text] [Related]
8. CGRRF1 as a novel biomarker of tissue response to metformin in the context of obesity.
Zhang Q; Schmandt R; Celestino J; McCampbell A; Yates MS; Urbauer DL; Broaddus RR; Loose DS; Shipley GL; Lu KH
Gynecol Oncol; 2014 Apr; 133(1):83-9. PubMed ID: 24680596
[TBL] [Abstract][Full Text] [Related]
9. Proliferation and metastatic potential of endometrial cancer cells in response to metformin treatment in a high versus normal glucose environment.
de Barros Machado A; Dos Reis V; Weber S; Jauckus J; Brum IS; von Eye Corleta H; Strowitzki T; Capp E; Germeyer A
Oncol Lett; 2016 Nov; 12(5):3626-3632. PubMed ID: 27900046
[TBL] [Abstract][Full Text] [Related]
10. Systematic review and meta-analysis of the effect of metformin treatment on overall mortality rates in women with endometrial cancer and type 2 diabetes mellitus.
Perez-Lopez FR; Pasupuleti V; Gianuzzi X; Palma-Ardiles G; Hernandez-Fernandez W; Hernandez AV
Maturitas; 2017 Jul; 101():6-11. PubMed ID: 28539171
[TBL] [Abstract][Full Text] [Related]
11. Metformin Increases E-cadherin in Tumors of Diabetic Patients With Endometrial Cancer and Suppresses Epithelial-Mesenchymal Transition in Endometrial Cancer Cell Lines.
Laskov I; Abou-Nader P; Amin O; Philip CA; Beauchamp MC; Yasmeen A; Gotlieb WH
Int J Gynecol Cancer; 2016 Sep; 26(7):1213-21. PubMed ID: 27643646
[TBL] [Abstract][Full Text] [Related]
12. Metformin Regulates TET2 Expression to Inhibit Endometrial Carcinoma Proliferation: A New Mechanism.
Zhang J; Kuang L; Li Y; Wang Q; Xu H; Liu J; Zhou X; Li Y; Zhang B
Front Oncol; 2022; 12():856707. PubMed ID: 35480097
[TBL] [Abstract][Full Text] [Related]
13. Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
Sarfstein R; Friedman Y; Attias-Geva Z; Fishman A; Bruchim I; Werner H
PLoS One; 2013; 8(4):e61537. PubMed ID: 23620761
[TBL] [Abstract][Full Text] [Related]
14. Antitumor effects of metformin via indirect inhibition of protein phosphatase 2A in patients with endometrial cancer.
Hanawa S; Mitsuhashi A; Shozu M
PLoS One; 2018; 13(2):e0192759. PubMed ID: 29444159
[TBL] [Abstract][Full Text] [Related]
15. Diabetes mellitus and endometrial carcinoma: Risk factors and etiological links.
Wang Y; Zeng X; Tan J; Xu Y; Yi C
Medicine (Baltimore); 2022 Aug; 101(34):e30299. PubMed ID: 36042597
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of metformin in the treatment of endometrial cancer.
Mu N; Xu T; Gao M; Dong M; Tang Q; Hao L; Wang G; Li Z; Wang W; Yang Y; Hou J
Oncol Lett; 2020 Nov; 20(5):156. PubMed ID: 32934724
[TBL] [Abstract][Full Text] [Related]
17. Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer.
Laskov I; Drudi L; Beauchamp MC; Yasmeen A; Ferenczy A; Pollak M; Gotlieb WH
Gynecol Oncol; 2014 Sep; 134(3):607-14. PubMed ID: 24972190
[TBL] [Abstract][Full Text] [Related]
18. Reversal of obesity-driven aggressiveness of endometrial cancer by metformin.
Guo H; Kong W; Zhang L; Han J; Clark LH; Yin Y; Fang Z; Sun W; Wang J; Gilliam TP; Lee D; Makowski L; Zhou C; Bae-Jump VL
Am J Cancer Res; 2019; 9(10):2170-2193. PubMed ID: 31720081
[TBL] [Abstract][Full Text] [Related]
19. The Usefulness of Diagnostic Panels Based on Circulating Adipocytokines/Regulatory Peptides, Renal Function Tests, Insulin Resistance Indicators and Lipid-Carbohydrate Metabolism Parameters in Diagnosis and Prognosis of Type 2 Diabetes Mellitus with Obesity.
Komosinska-Vassev K; Gala O; Olczyk K; Jura-Półtorak A; Olczyk P
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32917052
[TBL] [Abstract][Full Text] [Related]
20. Metformin Promotes Anti-tumor Biomarkers in Human Endometrial Cancer Cells.
Pabona JMP; Burnett AF; Brown DM; Quick CM; Simmen FA; Montales MTE; Liu SJ; Rose T; Alhallak I; Siegel ER; Simmen RC
Reprod Sci; 2020 Jan; 27(1):267-277. PubMed ID: 32046384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]